BioWorld

Nov. 29, 2005

View Archived Issues

Targeted Genetics' Stock Surges On NIH Grant For HIV Vaccine

Read More

IDM Sells Assets To Pharmexa For $12M To Focus On Cancer

Read More

Other News To Note

Read More

ABI In $4B Merger With APP To Create Abraxis BioScience

American BioScience Inc. and its majority-owned subsidiary, American Pharmaceutical Partners Inc., are combining to create a new company, Abraxis BioScience. (BioWorld Today) Read More

Pfizer Begins Phase III Studies With Coley's NSCLC Therapy

Read More